Creatine Monohydrate Group
|
Average Power % Decline Change
|
Phosphocreatine Disodium Salts Plus Blueberry Extract Group
|
Average Power % Decline Change
|
Placebo Group
|
Average Power % Decline Change
|
---|
1
|
0.07
|
1
|
11.37
|
1
|
6.64
|
2
|
5.16
|
2
|
9.15
|
2
|
10.17
|
3
|
0.17
|
3
|
−38.13a
|
3
|
11.39
|
4
|
6.49
|
4
|
14.25
|
4
|
−31.44a
|
5
|
−24.55a
|
5
|
18.79
|
5
|
−2.65
|
6
|
1.77
|
6
|
10.74
|
6
|
−13.68a
|
7
|
14.64
|
7
|
3.93
|
7
|
11.36
|
8
|
27.96
|
8
|
30.52
|
8
|
−12.37a
|
9
|
23.68
|
9
|
21.32
|
9
|
−0.97
|
10
|
6.81
|
10
|
5.80
|
10
|
24.92
|
11
|
8.16
|
11
|
15.70
| | |
12
|
−7.31
| | | | |
Proportion exceeding the minimal important difference
|
1 of 12 (8%)
| |
1 of 11 (9%)
| |
3 of 10 (30%)
|
- aIndicates a reduction in percent decline for average power that exceeded the minimal important difference (pooled pre-supplementation S.D. × 0.5 effect size = −10.51%)